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Abstract. Introduction: Salivary TBARS are a potential marker of oxidative stress in the oral cavity. Previous studies have found
increased levels of salivary TBARS in various diseases. The aim of this study was to assess the variability of salivary TBARS in
both genders.
Subjects & Methods: Saliva samples from thirty-eight healthy volunteers (18F & 20M) were collected every day during 30 day
period. TBARS levels were measured spectrophotometrically using a high-throughput 96-well plate method. Time series analysis
was performed using standard statistical methods.
Results: Repeated measures ANOVA showed a significant variation of salivary TBARS within day and subjects (p < 0.001). The
dynamics did not differ between genders. Intraindividual variability was very high in both genders with coefficients of variation
of more than 60%. Interindividual variability was higher in men than in women (73% vs. 46%; p < 0.01).
Discussion: The relatively high intraindividual variability indicates that the use of salivary TBARS will be limited to research on
a population level, although some informative value might be gained by repeated samplings. Factors influencing the biological
variability of salivary TBARS should be identified in further studies.
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1. Introduction
Thiobarbituric acid reacting substances (TBARS) are
produced during the oxidative stress-induced damage
of lipids, i.e. lipoperoxidation. They represent a het-
erogeneous group of compounds. Malondialdehyde
(MDA) is the best known TBARS compound. TBARS
are widely used as a marker of oxidative stress in the
plasma [25] and different types of tissues [8]. Urinary
MDA is considerably affected by exogenous factors in-
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cluding diet and air pollution and, thus, is rarely used
in research [12,18].
In a previous study, we have shown that TBARS are
measurable in saliva [10] and that their levels are high-
er in patients with gingivitis [14]. In addition, the re-
sults from our studies indicate that levels of TBARS in
plasma and saliva do not correlate, suggesting that sali-
vary TBARS can represent a marker specific for local
(oral) disorders and could be useful for assessing oral
status and efficacy of treatment oral diseases. How-
ever, in some studies increased salivary TBARS levels
were found in patients suffering from disease primarily
affecting extraoral tissues – such as osteoporosis [31],
Crohn’s disease [16] and ulcerative colitis [23].
Other authors have confirmed our results with find-
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ings of increased salivary MDA levels, but similar plas-
ma MDA levels have not been found in patients with
chronic periodontitis compared to healthy controls [3].
The origin and the composition of TBARS in saliva
remain unclear. One of the key issues is to identify
the cause of increased TBARS levels. There are al-
ready known factors influencing salivary TBARS lev-
els beyond diseases. It has been repeatedly shown that
smoking increases salivary MDA levels, at least in den-
tal patients [11,13]. Cadmium and some drugs induce
lipoperoxidation directly in the salivary gland [1,2].
Moreover, TBARS levels in saliva are affected by the
time of sampling, tooth-brushing and ascorbic acid pre-
treatment [14]. Details of interindividual (among indi-
viduals) and intraindividual (among days of sampling
within one individual subject) variability of TBARS
levels in saliva are unknown. The aim of our study was
to analyze the interindividual and intraindividual vari-
ability of salivary TBARS in young healthy volunteers
and to describe potential gender differences.
2. Subjects and methods
Samples of saliva were collected from 18 young
healthy female volunteers with an average age of 23.4±
3.0 years and 20 young healthy male volunteers with
an average age of 25.4 ± 3.1 years. The volunteers
were instructed to collect whole saliva samples without
the use of any stimulants, daily in the morning during
a period of 30 consecutive days. Behavioural habits
which may influence the salivary TBARS levels were
monitored using a questionnaire. Sampling was carried
out 10 minutes after tooth-brushing and the volunteers
were instructed not to eat before sampling. Collected
saliva samples were immediately frozen at−20◦C until
measurement.
Salivary TBARS were determined by the spectropho-
tometric method after derivatization with 0.67 % thio-
barbituric acid in 1.5 mol/l acidic medium of acetic acid
(95◦C, 45 min). Before derivatization, the samples in
collection tubes were centrifuged (3000 g, 10 min) and
supernatants (0.5 ml) were transferred to the deep-well
plates. After derivatization, the colored product was
extracted with 0.5 ml of n-butanol, centrifuged (2250 g,
10 min), transferred 0.25 ml to the spectrophotometric
96 well plate and measured (λex. = 515 nm, λem. =
535 nm, Safire 2, Tecan). TBARS concentration was
expressed as µmol/l of saliva on the basis of the calibra-
tion curve of 1,1,3,3-tetrametoxypropan standard. All
30 samples of each volunteer were measured in separate
plates. Calibration curve was prepared for each plate
in triplicates. For evaluation of intra- and inter-plate
TBARS variability caused by methodological bias the
plate assay reliability was determined using coefficient
of variation.
The data was analysed by repeated measured ANO-
VA (analyzed factors were time of sampling – day as
within factor, subject as subject variable and gender as
between factor) and F-test for the comparison of vari-
ability between genders. The level of significance was
set to 0.05. All statistical analyses were performed
using NCSS 2007 and Origin 6 software.
3. Results
Salivary TBARS levels did not differ between gen-
ders (Fig. 1). Repeated measured ANOVA showed sig-
nificant influence of sampling day as a factor affect-
ing the variability of salivary TBARS (F = 2.85; p <
0.001). Intraindividual variability was very high in both
genders with coefficients of variation (CV) of more
than 60% (Fig. 2). Salivary TBARS levels varied be-
tween the subjects considerably (F = 14.8; p < 0.001).
The interindividual variability was higher in men than
in women (73% vs. 46%; p < 0.01) (Fig. 3). The
inter-plate TBARS variability was 4.23 % and the intra-
plate TBARS variability expressed by CV was 3.79 %.
These inter- and intra-plate CV values are sufficiently
low to use the microplate method for high-throughput
measurement of TBARS levels in saliva.
4. Discussion
Salivary markers of oxidative stress (MDA, TBARS
or protein carbonyls) and antioxidants have been an-
alyzed in clinical studies involving subjects with var-
ious conditions, including diabetes [5,17,24], aphtous
ulceration [28], Alzheimer disease [30] and periodon-
titis [11,20]. Further studies are running. There is a
clear need for a biochemical evaluation of these sali-
vary parameters. This is the first study dealing with
the variability of a salivary marker of oxidative stress.
TBARS are widely used, although sometimes report-
ed as MDA. We have decided to follow the consensus
to use the term TBARS for colorimetric measurements
and MDA for chromatographic methods. Based on our
previous results, it seems that more than half of the sali-
vary TBARS is MDA, but a detailed targeted analysis
is needed.
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Fig. 1. Salivary TBARS levels in men and women. All analyzed samples are plotted.
Fig. 2. Intraindividual variability of TBARS levels among 30 days of sampling. No gender difference has been found.
Jens Lykkesfeldt has pointed out problems with the
interpretation of MDA levels in a recent review [19]. A
major issue is the analytical method, as the results seem
to vary extremely between laboratories and are actually
not comparable. Adhering to standard analytical meth-
ods and especially, the correct reporting on the used
methods in the manuscripts is extremely important for
the reproducibility and comparability of results. The
method used in this study is described in detail and
can be easily reproduced. Furthermore, the microplate-
based analysis using pippeting robots and microplate
spectrophotometer enables a high-throughputapproach
and decreases the analytical variability to a satisfactory
low level.
In this study we have found an extremely high
intraindividual and interindividual variability which
makes the interpretation of individual values difficult,
if not impossible. Such high variance may lead to false
negative results in experiments and clinical trials an-
alyzing salivary TBARS, which are then often not re-
ported in the literature due to publication bias. A pre-
viously published analysis of plasma MDA levels re-
vealed an average CV of 18% (intraindividual) and 24%
(interindividual) with a conclusion that the use of this
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Fig. 3. Interindividual variability of TBARS levels among 30 days of sampling. The variability in men was significantly higher than in women.
marker for individual diagnostics is questionable [21].
Although a comparison is biased due to different co-
horts (age 20–79 years vs. age 18–28 years) and other
analytical methods (HPLC vs. spectrophotometry), it
seems that the biological variability in saliva is even
higher than in plasma.
Principally, there are two potential ways how to cope
with biological variability – repeated sampling and
identification of sources of variability. Only the latter
will, however, enable a wider use of salivary TBARS in
research. Previous studies have shown that the levels
of TBARS/MDA undergo temporal changes including
potentially endogenous diurnal [9,14,27] and seasonal
variations probably induced by changes of nutritional
composition [4,6,29]. In our study the effects of sea-
sonal and diurnal variations can be excluded, as the
sampling was done in the same time and same season
in all subjects.
The dynamics of salivary TBARS levels did not dif-
fer between genders. However, the data was not syn-
chronized, and thus, gender differences in endogenous
dynamics cannot be ruled out. Notably, as plasma
MDA levels were found to be affected by gender in a re-
cent study [7] and estradiol decreases lipoperoxidation
as found previously [22].
Analysis of disease markers in saliva represents a
valuable tool for modern diagnostic approaches, main-
ly due to the non-invasive nature of sample collection
and the possibility of long-time monitoring [26]. The
production of saliva (or oral fluid) affects the salivary
concentrations of biomarkers to a highly variable ex-
tent, depending on the origin and the molecular size,
structure and characteristics of the biomarker [15]. As
the composition and source of salivary TBARS are cur-
rently unknown, it is difficult to estimate the proportion
of variability that might be explained. A consensus on a
normalization factor like creatinine in the urine or total
proteins in tissue homogenates in the future is needed.
The high intraindividual variability indicates that re-
peated samplings might improve the informative val-
ue of salivary TBARS. However, the use of this mark-
er will probably be limited to research on population
level. Gender differences and interindividual variabil-
ity should be taken into account in clinical studies on
patients with oral diseases. Other factors influencing
the variability of salivary TBARS including diet, com-
position of microbial flora and genetic polymorphisms
should be uncovered by further studies.
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